Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ZBHZimmer Biomet	STESteris	RVTYRevvity
Snapshot
Price	$100.44	$233.37	$130.37
Market cap	$17.28B	$21.27B	$12.69B
Valuation
P/E	25.5x	29.1x	61x
Forward P/E	29.9x	22.8x	68.3x
Growth
Revenue growth	9.2%	8.7%	4.8%
EPS growth	-14.6%	27.9%	-10.7%
Profitability
Net margin	9.1%	13.2%	8.3%
ROE	6.0%	11.1%	3.3%
Balance sheet & cash
Debt / equity	0.59x	0.27x	0.44x
Free cash flow yield	7.5%	5.4%	5.1%
Dividend yield	1.0%	1.2%	0.3%
Verdict
Investment rating	Neutral· 44	Favorable· 59	Weak· 30

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ZBHtoday $100	STEtoday $233	RVTYtoday $130
2027	$76.84 – $112.69+12% CAGR	$223.95 – $328.46+41% CAGR	$99.73 – $146.28+12% CAGR
2028	$78.37 – $114.95+7% CAGR	$286.54 – $420.26+34% CAGR	$101.73 – $149.20+7% CAGR
2029	$79.94 – $117.25+5% CAGR	$366.63 – $537.72+32% CAGR	$103.76 – $152.18+5% CAGR
2030	$81.54 – $119.59+4% CAGR	$469.10 – $688.02+31% CAGR	$105.84 – $155.23+4% CAGR
2031	$83.17 – $121.98+4% CAGR	$600.22 – $880.32+30% CAGR	$107.95 – $158.33+4% CAGR
5-yr CAGR	-3.7% – 4.0%	20.8% – 30.4%	-3.7% – 4.0%